Premium
Zimeldine treatment of obsessive‐compulsive disorder
Author(s) -
Kahn R. S.,
Westenberg H. G. M.,
Jolles J.
Publication year - 1984
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1984.tb02493.x
Subject(s) - obsessive compulsive , cognition , psychiatry , psychology , anxiety disorder , cognitive disorder , medicine , cognitive impairment , anxiety
– Six patients with Obsessive‐Compulsive Disorder (DSM III) were treated in an open uncontrolled trial with Zimeldine, for 8 weeks. All six patients had cognitive deficits before treatment. Five patients improved on the clinical symptoms. Four of these showed pronounced amelioration of their cognitive deficits.